Basis: (FMP quote price / unrounded diluted TTM EPS) / explicitly dated EPS growth percent. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-09-10T14:30:33.000Z.
Quote observation: 2026-09-10T14:30:33.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: af83445863c5cbd0ce920ec438e85bb38c520832abb93cce62fb5a9f53d58986
PEG RATIO
N/A
Solventum Corporation
Market Cap
$15.51B
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Solventum Corporation (SOLV) | $15.51B | N/A |
| Medpace Holdings, Inc. (MEDP)vs › | $16.27B | N/A |
| Exelixis, Inc. (EXEL)vs › | $14.56B | N/A |
| Revvity, Inc. (RVTY)vs › | $13.61B | N/A |
| Charles River Laboratories International, Inc. (CRL)vs › | $13.19B | N/A |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.02B | N/A |
| Penumbra, Inc. (PEN)vs › | $12.57B | N/A |
| Baxter International Inc. (BAX)vs › | $12.54B | N/A |
| Viatris Inc. (VTRS)vs › | $18.90B | N/A |
| Encompass Health Corporation (EHC)vs › | $12.08B | N/A |
PEG Ratio
N/A
P/E Ratio
10.9
PEG Ratio = PE Ratio / Earnings Growth Rate
The PEG ratio adjusts the PE ratio for expected earnings growth. A PEG near 1 is often considered fairly valued relative to growth.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
